Videos

Press Releases

  • News,Press release,Quality of Life Group

    EORTC Quality of Life Group celebrating 40 years

  • EORTC Item Library provides considerable coverage of CTCAE side effects

    News,Press release,Quality of Life Group

    EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds

  • PRESS RELEASE: Better treatment for better heath: lifting the veil on treatment optimisation

    News,Press release

    PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation

  • Lung

    Lung Cancer Group,News,Press release

    MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression

Latest Newsletter

News

Filter on topic